165 related articles for article (PubMed ID: 6446260)
1. Treatment of experimental Haemophilus influenzae type b meningitis with 1-oxa-beta-lactam (LY127935).
Cordera CS; Pekarek RS
Antimicrob Agents Chemother; 1980 Feb; 17(2):258-62. PubMed ID: 6446260
[TBL] [Abstract][Full Text] [Related]
2. [Haemophilus influenzae type b meningitis resistant to ampicillin and chloramphenicol treated with moxalactam].
Gómez-Acebo F; Palenque E; Scarpellini Vera A; Rodríguez Otero JJ; Fernández Epifanio JL
An Esp Pediatr; 1983 May; 18(5):410-1. PubMed ID: 6225361
[No Abstract] [Full Text] [Related]
3. Pharmacokinetics and bacteriological efficacy of moxalactam (LY127935), netilmicin, and ampicillin in experimental gram-negative enteric bacillary meningitis.
Schaad UB; McCracken GH; Loock CA; Thomas ML
Antimicrob Agents Chemother; 1980 Mar; 17(3):406-11. PubMed ID: 6448576
[TBL] [Abstract][Full Text] [Related]
4. In vitro activities of cefotaxime and moxalactam (LY127935) against Haemophilus influenzae.
Jorgensen JH; Crawford SA; Alexander GA
Antimicrob Agents Chemother; 1980 Mar; 17(3):516-7. PubMed ID: 6252832
[TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibility of 104 clinical isolates of Haemophilus influenzae to moxalactam (LY127935), ampicillin, chloramphenicol, and ticarcillin.
Mason EO; Kaplan SL; Anderson DC; Hinds DB; Feigin RD
Antimicrob Agents Chemother; 1980 Mar; 17(3):470-3. PubMed ID: 6448579
[TBL] [Abstract][Full Text] [Related]
6. Studies of moxalactam for gram-negative and Haemophilus influenzae meningitis: an appraisal.
Dillon HC
J Pediatr; 1981 Dec; 99(6):907-8. PubMed ID: 6458672
[No Abstract] [Full Text] [Related]
7. Comparative activities of moxalactam (LY 127935) a new semisynthetic 1-oxa-beta lactam antibiotic with 7 other antibiotics against type b Haemophilus influenzae.
Chu ML; Harms JL; Liu C
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1981 Sep; 14(3):146-55. PubMed ID: 6456875
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and therapeutic efficacy of imipenem, ceftazidime, and ceftriaxone in experimental meningitis due to an ampicillin- and chloramphenicol-resistant strain of Haemophilus influenzae type b.
Sakata Y; McCracken GH; Thomas ML; Olsen KD
Antimicrob Agents Chemother; 1984 Jan; 25(1):29-32. PubMed ID: 6322679
[TBL] [Abstract][Full Text] [Related]
9. In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains.
Baker CN; Thornsberry C; Jones RN
Antimicrob Agents Chemother; 1980 Apr; 17(4):757-61. PubMed ID: 6249195
[TBL] [Abstract][Full Text] [Related]
10. Limited in vitro activity of cefamandole against 100 beta-lactamase- and non-beta-lactamase-producing Haemophilus influenzae strains: comparison of moxalactam, chloramphenicol, and ampicillin.
Bergeron MG; Claveau S; Simard P
Antimicrob Agents Chemother; 1981 Jan; 19(1):101-5. PubMed ID: 6454379
[TBL] [Abstract][Full Text] [Related]
11. The in vitro antibacterial activity of LY127935 (6059S), a novel 1-oxa-beta-lactam antibiotic.
Warren CA; King BA; Shannon KP; Eykyn SJ; Phillips I
J Antimicrob Chemother; 1980 Sep; 6(5):607-15. PubMed ID: 6447682
[No Abstract] [Full Text] [Related]
12. Antibiotic therapy of meningitis caused by ampicillin-resistant Haemophilus influenzae in Denmark and Greenland 1981 to 1987.
Cordtz T; Jepsen OB; Arpi M; Hønberg P
Eur J Clin Microbiol Infect Dis; 1988 Oct; 7(5):646-50. PubMed ID: 3143574
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and bacteriological efficacy of cefoperazone, ceftriaxone, and moxalactam in experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis.
McCracken GH; Nelson JD; Grimm L
Antimicrob Agents Chemother; 1982 Feb; 21(2):262-7. PubMed ID: 6280599
[TBL] [Abstract][Full Text] [Related]
14. Comparative in vitro and in vivo activity of temocillin (BRL 17421) and ampicillin against Haemophilus influenzae type b.
Yogev R; Glogowski W; Connor E
Antimicrob Agents Chemother; 1983 Jan; 23(1):182-4. PubMed ID: 6600909
[TBL] [Abstract][Full Text] [Related]
15. Synergistic action of nafcillin and ampicillin against ampicillin-resistant Haemophilus influenzae type b bacteremia and meningitis in infant rats.
Yogev R; Kabat WJ
Antimicrob Agents Chemother; 1980 Jul; 18(1):122-4. PubMed ID: 6968176
[TBL] [Abstract][Full Text] [Related]
16. In vitro studies of moxalactam (LY127935), a new beta-lactam antibiotic with significant activity against gram-negative bacteria.
DeMaria A; Alvarez S; Klein JO; McCabe WR
Infection; 1980; 8 Suppl 3():S 261-7. PubMed ID: 6447671
[TBL] [Abstract][Full Text] [Related]
17. Failure of cefamandole in treatment of meningitis due to Haemophilus influenzae type b.
Steinberg EA; Overturf GD; Wilkins J; Baraff LJ; Streng JM; Leedom JM
J Infect Dis; 1978 May; 137 Suppl():S180-S189. PubMed ID: 306403
[TBL] [Abstract][Full Text] [Related]
18. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
Hall WH; Opfer BJ; Gerding DN
Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic activity of ceftazidime and eleven other beta-lactam antibiotics against experimental Haemophilus influenzae, type b meningitis.
McColm AA; Ryan DM
J Antimicrob Chemother; 1984 May; 13(5):517-20. PubMed ID: 6376459
[TBL] [Abstract][Full Text] [Related]
20. Moxalactam (LY127935) in treatment of meningitis due to gram-negative bacilli.
Fisher JF; Carter MJ; Parsons J; Rissing JP
Antimicrob Agents Chemother; 1981 Feb; 19(2):218-21. PubMed ID: 6214985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
